Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03193619 · ClinicalTrials.gov registry record
Real World Registry Assessing the Clinical Use of the Bard UltraScore Forced Focus PTA Balloon
A clinical trial, sponsored by C. R. Bard.
- Completed
- Registry status
- 350
- Enrollment target
NCT03193619 is a clinical trial that has completed, run by C. R. Bard. The registered enrollment target is 350 participants.
The verdict
NCT03193619 has completed, sponsored by C. R. Bard.
- COMPLETED
- Registry status
- 350 participants
- Enrollment target
Study Summary
The objective of this study is to assess the clinical use of the Bard® UltraScore™ Focused Force PTA balloon in a heterogeneous patient population in a real world, on-label clinical application.
Interventions
- DEVICE PTA (UltraScore Focused Force PTA Balloon)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2018-03-28 |
| Est. Completion | 2022-04-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03193619
The ClinicalTrials.gov registry entry for NCT03193619 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is C. R. Bard, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PTA (UltraScore Focused Force PTA Balloon) is the first listed.
NCT03193619 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03193619 about?
NCT03193619 is a clinical study titled "Real World Registry Assessing the Clinical Use of the Bard UltraScore Forced Focus PTA Balloon". The objective of this study is to assess the clinical use of the Bard® UltraScore™ Focused Force PTA balloon in a heterogeneous patient population in a real world, on-label clinical application.
What is the current status of trial NCT03193619?
This trial is currently completed. The enrollment target is 350 participants. The study started on 2018-03-28. Estimated completion is 2022-04-01.
What interventions are being tested in trial NCT03193619?
The interventions under investigation include: PTA (UltraScore Focused Force PTA Balloon) (DEVICE).
Who is sponsoring clinical trial NCT03193619?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.